Please login to the form below

Not currently logged in
Email:
Password:

PRIME designation

This page shows the latest PRIME designation news and features for those working in and with pharma, biotech and healthcare.

Roche’s Evrysdi improves survival rates for infants with SMA

Roche’s Evrysdi improves survival rates for infants with SMA

The drug was granted prime designation by the European Medicines Agency (EMA) in 2018 and Orphan Drug Designation by the US Food and Drug Administration in 2017.

Latest news

More from news
Approximately 2 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    The 11 drugs identified collectively hold 18 orphan drug designations, four FDA breakthrough therapy designations, two EU PRIME designations and one Japanese SAKIGAKE designation.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    Bluebird says its decision to file in Europe first was in part thanks to LentiGlobin being accepted on to the EMA’s PRIME fast track designation, which allows early discussions about ... Upadacitinib is already in a phase 3 trial in atopic dermatitis

  • The European Medicines Agency: PRIME’d for access? The European Medicines Agency: PRIME’d for access?

    Going for scientific advice once given the PRIME designation can also mean faster advice: a 40-day timeframe versus the 70-day standard. ... SMEs can also get a filing fee reduction. PRIME numbers after 2 years.

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    There is no question that these products are truly groundbreaking: three have FDA Breakthrough Therapy Designation and two have the similar PRIME designation from the EMA. ... European regulator giving the therapy its PRIME designation in September 2016.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...